NEWS

Latest in Stem Cell Research

  • A recent research by Cleaveland Clinic could establish mesenchymal stem cell transplantation as an innovative, safe, efficacious and cost-effective treatment for pain and opioid tolerance. Across the world, millions of people suffer under various pain states including cancer pain or other chronic pain and their treatment involves long-term opioid therapy through morphine injections. The flipside […]

    Read more
  • Richard Burt, MD, of Northwestern University is looking to harness the power of autologous, patient-derived stem cells for the treatment of systemic sclerosis. His previous work in a clinical trial with scleroderma motivated a new phase 3 clinical trial, entitled “Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial (DIScl2011).” The trial is currently recruiting up […]

    Read more
  • Testing breast cancer cells for how closely they resemble stem cells could identify women with the most aggressive disease, a new study suggests. Researchers found that breast cancers with a similar pattern of gene activity to that of adult stem cells had a high chance of spreading to other parts of the body. Assessing a […]

    Read more
  • bebé prematuro

    Wang Cansen from China was diagnosed with leukaemia at the age of four. Doctors informed his parents that without a transplant, he would die so his parents had to apply for special permission to have a second baby. Baby girl, born on January is a perfect donor match for her brother. Doctors have been able […]

    Read more
  • Adriana was born in Italy in 2009 after an in vitro fertilization and her parents were finally achieving the dream of their lives. Everything appeared to be fine with the pregnancy until the last moment when the mother started to feel contractions and ran to the clinic. She had forgotten to bring the kit for […]

    Read more
  • When stem cells are used to regenerate bone tissue many migrate away from the repair site. A research team led by Assistant Professor of Biomedical Engineering Danielle Benoit, at the University of Rochester (USA), has used a technique that keeps the stem cells in place resulting in faster and better tissue regeneration. Hydrogel polymers are […]

    Read more
  • Far from being sharply divided, the American people are in broad support of more stem cell research, according to the results of an online survey released by Cord Blood Registry® (CBR®) to coincide with National Cord Blood Awareness Month. The poll included responses from 1,130 individuals to reveal: their belief in the need for continued research […]

    Read more
  • The latest clinical trial to explore the therapeutic potential of cord blood launched this month with a focus on autism. This is a very big deal because autism is a very common condition. In recent years the number of children with autism has been rising, and no one knows why. A few months ago the […]

    Read more
  • During the last 25 years, stem cells derived from umbilical cord blood have been used in more than 30,000 transplants performed worldwide for the treatment of over 80 diseases and disorders in both adults and children. The evolution of stem cell therapies has paved the way for further research being conducted through FDA-regulated clinical trials […]

    Read more
  • A new study describes the complexity of the new T cell repertoire following immune-depleting therapy to treat multiple sclerosis, improving our understanding of immune tolerance and clinical outcomes. In the Immune Tolerance Network’s (ITN) HALT-MS study, 24 patients with relapsing, remitting multiple sclerosis received high-dose immunosuppression followed by a transplant of their own stem cells, […]

    Read more
  • Enhancing the brain’s inherent ability to rebuild itself after a stroke with molecular components of stem cells holds enormous promise for treating the leading cause of long-term disability in adults. Michael Chopp, Ph.D., Scientific Director of the Henry Ford Neuroscience Institute, presented this approach to treating neurological diseases at the American Heart Association’s International Stroke […]

    Read more
  • Foreskin-derived stem cells have therapeutic potential for the currently untreatable condition congenital muscular dystrophy (CMD), according to a proof of concept study published in the journal Stem Cell Research and Therapy. CMD is a group of genetic conditions that usually presents at, or soon after, birth resulting in muscle weakness. There is currently no cure […]

    Read more
1 2 3 4 5